Daily News Podcast

Genetic signature helps ID MS risk

Publish date: March 20, 2019

 

Potential advances in precision medicine could reshape multiple sclerosis care. Also today, the CDC has a plan to cut undiagnosed and untreated HIV, which patients who have diabetes benefit the most from long-term metformin, and why amlodopine may be the best choice for lowering blood pressure in black patients.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Trump targets abortion by denying family planning funds
MDedge Endocrinology
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Endocrinology
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Endocrinology
Esketamine gets the green light for depression
MDedge Endocrinology
Ready for universal hepatitis C testing?
MDedge Endocrinology
Autism risk with in utero infections
MDedge Endocrinology
Aspirin and lower risk of COPD flare-up
MDedge Endocrinology
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Endocrinology
Bempedoic acid: funny name, serious LDL lowering
MDedge Endocrinology
First primary prevention CVD guidelines form ACC, AHA
MDedge Endocrinology